# The Effect of Adalimumab on the Bone Microstructure in Crohn's Disease (CD) Patients

> **NCT01012570** · — · TERMINATED · sponsor: **Gerhard Rogler** · enrollment: 34 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** Application of Adalimumab

## Key facts

- **NCT ID:** NCT01012570
- **Lead sponsor:** Gerhard Rogler
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2009-08
- **Primary completion:** 2011-08
- **Final completion:** —
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** not enough patients enrolled
- **Last updated:** 2014-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01012570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01012570, "The Effect of Adalimumab on the Bone Microstructure in Crohn's Disease (CD) Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01012570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*